RHCGF OTC
Ryman Healthcare Limited
1W: +0.0%
1M: -24.3%
3M: +3.7%
YTD: -36.0%
1Y: -21.7%
3Y: -69.1%
5Y: -87.0%
$1.12
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$323M
-21.3% ▼
5Y CAGR: -3.0%
Capital Expenditures
$48M
+55.5% ▲
5Y CAGR: -26.9%
Free Cash Flow
$275M
-9.2% ▼
5Y CAGR: +13.3%
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$8M
+67.6% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $693M | $258M | $0 | $0 | -$173M |
| Depreciation & Amort. | $36M | $47M | $0 | $0 | $43M |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | $570M | $664M | $667M | $0 | $384M |
| Other Non-Cash Items | -$527M | -$195M | -$8M | $410M | $75M |
| Operating Cash Flow | $536M | $543M | $658M | $410M | $323M |
| — Investing Activities — | |||||
| Capital Expenditures | -$299M | -$324M | -$264M | -$104M | -$48M |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $75M |
| Investment Purchases | -$434M | -$609M | -$583M | -$377M | -$162M |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | -$4M | $1M | $5M | -$45M | $368K |
| Investing Cash Flow | -$737M | -$932M | -$842M | -$526M | -$135M |
| — Financing Activities — | |||||
| Net Debt Issuance | $327M | $437M | $201M | -$881M | -$194M |
| Stock Repurchased | -$3M | $0 | -$352K | $0 | $0 |
| Dividends Paid | -$112M | -$68M | $0 | $0 | $0 |
| Other Financing | -$3M | -$859M | -$3M | -$4M | -$4M |
| Financing Cash Flow | $209M | $389M | $198M | $91M | -$196M |
| Net Change in Cash | $8M | -$430K | $14M | -$24M | -$8M |
| Cash End of Period | $28M | $28M | $42M | $18M | $10M |
| Free Cash Flow | $237M | $219M | $486M | $303M | $275M |